MiMedx Group, Inc. (MDXG) stock
MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 12/3040% below fair value
$3.18+0.00 (0.00%)
Close on Nov 17, 2026Market cap $464.04MP/E –Yield –
MiMedx r&d expenses
Research and development expenses are spending on new products and technology.
MiMedx's R&D Expenses for the twelve months ending Sep 30, 2026 was $14.47M, up 4.1% year over year. For fiscal 2025 it was $15.10M, up 22.3% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is $17.90M in fiscal 2017.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.10M | +22.3% |
| FY2024 | Dec 31, 2024 | $12.34M | -2.6% |
| FY2023 | Dec 31, 2023 | $12.67M | -0.3% |
| FY2022 | Dec 31, 2022 | $12.70M | +27.9% |
| FY2021 | Dec 31, 2021 | $9.93M | -15.2% |
| FY2020 | Dec 31, 2020 | $11.72M | +5.2% |
| FY2019 | Dec 31, 2019 | $11.14M | -29.3% |
| FY2018 | Dec 31, 2018 | $15.77M | -11.9% |
| FY2017 | Dec 31, 2017 | $17.90M | +24.8% |
| FY2016 | Dec 31, 2016 | $14.34M | +70.5% |
| FY2015 | Dec 31, 2015 | $8.41M | +19.3% |
| FY2014 | Dec 31, 2014 | $7.05M | +45.6% |
| FY2013 | Dec 31, 2013 | $4.84M | +67.9% |
| FY2012 | Dec 31, 2012 | $2.89M | -3.1% |
| FY2011 | Dec 31, 2011 | $2.98M | +8.1% |
| FY2010 | Dec 31, 2010 | $2.75M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.80M | -24.5% |
| Q2 FY2026 | Jun 30, 2026 | $2.78M | -15.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.14M | +24.4% |
| Q4 FY2025 | Dec 31, 2025 | $4.76M | +33.3% |
| Q3 FY2025 | Sep 30, 2025 | $3.70M | +26.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.30M | +9.7% |
| Q1 FY2025 | Mar 31, 2025 | $3.33M | +17.1% |
| Q4 FY2024 | Dec 31, 2024 | $3.57M | +46.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.92M | -5.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.01M | -18.0% |
| Q1 FY2024 | Mar 31, 2024 | $2.84M | -18.5% |
| Q4 FY2023 | Dec 31, 2023 | $2.43M | -54.9% |
| Q3 FY2023 | Sep 30, 2023 | $3.08M | -48.3% |
| Q2 FY2023 | Jun 30, 2023 | $3.67M | -33.4% |
| Q1 FY2023 | Mar 31, 2023 | $3.48M | -41.6% |
| Q4 FY2022 | Dec 31, 2022 | $5.40M | +18.1% |
| Q3 FY2022 | Sep 30, 2022 | $5.95M | +36.3% |
| Q2 FY2022 | Jun 30, 2022 | $5.51M | +35.7% |
| Q1 FY2022 | Mar 31, 2022 | $5.96M | +37.5% |
| Q4 FY2021 | Dec 31, 2021 | $4.57M | +33.2% |
| Q3 FY2021 | Sep 30, 2021 | $4.37M | +29.5% |
| Q2 FY2021 | Jun 30, 2021 | $4.06M | +79.9% |
| Q1 FY2021 | Mar 31, 2021 | $4.34M | +63.7% |
| Q4 FY2020 | Dec 31, 2020 | $3.43M | +26.3% |
| Q3 FY2020 | Sep 30, 2020 | $3.37M | +25.3% |
| Q2 FY2020 | Jun 30, 2020 | $2.26M | -20.1% |
| Q1 FY2020 | Mar 31, 2020 | $2.65M | -8.7% |
| Q4 FY2019 | Dec 31, 2019 | $2.72M | -40.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.69M | -32.1% |
| Q2 FY2019 | Jun 30, 2019 | $2.83M | -24.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.90M | -18.1% |
| Q4 FY2018 | Dec 31, 2018 | $4.54M | +30.8% |
| Q3 FY2018 | Sep 30, 2018 | $3.96M | -27.7% |
| Q2 FY2018 | Jun 30, 2018 | $3.72M | -21.7% |
| Q1 FY2018 | Mar 31, 2018 | $3.55M | -15.6% |
| Q4 FY2017 | Dec 31, 2017 | $3.47M | -39.7% |
| Q3 FY2017 | Sep 30, 2017 | $5.48M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.75M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.20M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.76M | – |
See a number that looks wrong?